HRS-9950

N/A

Report date: 2023/06/14 20:00:35
NME

Base Information

Drug NameHRS-9950
Drug Alias NameHRS-9950
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 8 agonists
TargetsToll like receptor 8
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangsu Hengrui Medicine Co LtdSuzhou Suncadia Biopharmaceuticals Co LtdShanghai Hengrui Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesRuikedi (Shanghai) biomedical Co LtdChengdu Suncadia Medicine Co LtdChengdu Xinyue Pharmaceutical Co Ltd +[6] 
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A